Cargando…

Economic Burden of Smoking in Iran: A Prevalence-Based Annual Cost Approach

OBJECTIVES: The burden of smoking on the health system and society is significant. The current study aimed to estimate the annual direct and indirect costs of smoking in Iran for the year 2014. METHODS: A prevalence-based disease-specific approach was used to determine costs associated with the thre...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezaei, Satar, Matin, Behzad Karami, Hajizadeh, Mohammad, Bazyar, Mohammad, Sari, Ali Akbari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747416/
https://www.ncbi.nlm.nih.gov/pubmed/29072438
http://dx.doi.org/10.22034/APJCP.2017.18.10.2867
_version_ 1783289270522347520
author Rezaei, Satar
Matin, Behzad Karami
Hajizadeh, Mohammad
Bazyar, Mohammad
Sari, Ali Akbari
author_facet Rezaei, Satar
Matin, Behzad Karami
Hajizadeh, Mohammad
Bazyar, Mohammad
Sari, Ali Akbari
author_sort Rezaei, Satar
collection PubMed
description OBJECTIVES: The burden of smoking on the health system and society is significant. The current study aimed to estimate the annual direct and indirect costs of smoking in Iran for the year 2014. METHODS: A prevalence-based disease-specific approach was used to determine costs associated with the three most common smoking-related diseases: lung cancer (LC), chronic obstructive pulmonary disease (COPD) and ischaemic heart disease (IHD). Data on healthcare utilization were obtained from an original survey, hospital records and questionnaires. The number of deaths was extracted from the global burden diseases study (GBD). The human capital approach was applied to estimate the costs of morbidity and mortality due to smoking-related diseases, classified as direct (hospitalization, outpatients and non-medical costs) and indirect (mortality and morbidity). RESULTS: The total economic cost of the three most common smoking-attributable diseases in Iran was US$1.46 billion in 2014, including US$1.05 billion (71.7%) in indirect and US$0.41 billion (28.3%) in direct costs. Direct costs of the three smoking-related diseases accounted for 1.6% of total healthcare expenditures and total costs were about 0.26% of Iran’s gross domestic product (GDP) in 2014. CONCLUSIONS: Our study indicated that smoking places a substantial economic burden on Iranian society. Therefore, sustained smoking cessation interventions and tobacco control policies are required to reduce the magnitude and extent of smoking-attributable costs in Iran.
format Online
Article
Text
id pubmed-5747416
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-57474162018-02-21 Economic Burden of Smoking in Iran: A Prevalence-Based Annual Cost Approach Rezaei, Satar Matin, Behzad Karami Hajizadeh, Mohammad Bazyar, Mohammad Sari, Ali Akbari Asian Pac J Cancer Prev Research Article OBJECTIVES: The burden of smoking on the health system and society is significant. The current study aimed to estimate the annual direct and indirect costs of smoking in Iran for the year 2014. METHODS: A prevalence-based disease-specific approach was used to determine costs associated with the three most common smoking-related diseases: lung cancer (LC), chronic obstructive pulmonary disease (COPD) and ischaemic heart disease (IHD). Data on healthcare utilization were obtained from an original survey, hospital records and questionnaires. The number of deaths was extracted from the global burden diseases study (GBD). The human capital approach was applied to estimate the costs of morbidity and mortality due to smoking-related diseases, classified as direct (hospitalization, outpatients and non-medical costs) and indirect (mortality and morbidity). RESULTS: The total economic cost of the three most common smoking-attributable diseases in Iran was US$1.46 billion in 2014, including US$1.05 billion (71.7%) in indirect and US$0.41 billion (28.3%) in direct costs. Direct costs of the three smoking-related diseases accounted for 1.6% of total healthcare expenditures and total costs were about 0.26% of Iran’s gross domestic product (GDP) in 2014. CONCLUSIONS: Our study indicated that smoking places a substantial economic burden on Iranian society. Therefore, sustained smoking cessation interventions and tobacco control policies are required to reduce the magnitude and extent of smoking-attributable costs in Iran. West Asia Organization for Cancer Prevention 2017 /pmc/articles/PMC5747416/ /pubmed/29072438 http://dx.doi.org/10.22034/APJCP.2017.18.10.2867 Text en Copyright: © Asian Pacific Journal of Cancer Prevention http://creativecommons.org/licenses/BY-SA/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Research Article
Rezaei, Satar
Matin, Behzad Karami
Hajizadeh, Mohammad
Bazyar, Mohammad
Sari, Ali Akbari
Economic Burden of Smoking in Iran: A Prevalence-Based Annual Cost Approach
title Economic Burden of Smoking in Iran: A Prevalence-Based Annual Cost Approach
title_full Economic Burden of Smoking in Iran: A Prevalence-Based Annual Cost Approach
title_fullStr Economic Burden of Smoking in Iran: A Prevalence-Based Annual Cost Approach
title_full_unstemmed Economic Burden of Smoking in Iran: A Prevalence-Based Annual Cost Approach
title_short Economic Burden of Smoking in Iran: A Prevalence-Based Annual Cost Approach
title_sort economic burden of smoking in iran: a prevalence-based annual cost approach
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747416/
https://www.ncbi.nlm.nih.gov/pubmed/29072438
http://dx.doi.org/10.22034/APJCP.2017.18.10.2867
work_keys_str_mv AT rezaeisatar economicburdenofsmokinginiranaprevalencebasedannualcostapproach
AT matinbehzadkarami economicburdenofsmokinginiranaprevalencebasedannualcostapproach
AT hajizadehmohammad economicburdenofsmokinginiranaprevalencebasedannualcostapproach
AT bazyarmohammad economicburdenofsmokinginiranaprevalencebasedannualcostapproach
AT sarialiakbari economicburdenofsmokinginiranaprevalencebasedannualcostapproach